<DOC>
	<DOCNO>NCT02143739</DOCNO>
	<brief_summary>The primary objective NIS evaluate severity newly diagnose asthma patient base Global Initiative Asthma ( GINA ) severity category ( GINA 2006 update ) .</brief_summary>
	<brief_title>The Severity Newly Diagnosed Asthma Patients Result Initial 12 Weeks Treatment China</brief_title>
	<detailed_description>This multi-centre , prospective non-interventional study plan conduct China . The study aim recruit 5000 newly diagnose patient 50 tier 3 hospital respiratory department . Each site recruit 50-150 patient . The primary variable distribution severity base GINA definition ( GINA 2006 update ) baseline total population . There 4 visit study , Informed consent follow study procedure ( ACQ-5 ( asthma control questionnaire ) , severity assessment ) do visit 1 . After , accord clinical practice China patient usually go clinic every 4 week . Asthma control status , ACQ-5 sever exacerbation assess clinic visit till 12 week ( visit 2 , 3 , 4 ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Newly diagnose asthma patient inhale gluococorticosteroid within 3 month . 2 . Outpatient age 18 year 3 . Signed date informed consent The prescription medicinal product clearly separated decision include subject NIS . Generally , asthma medication refers recommend GINA guideline ( GINA2012 update ) decide investigator . 1 . Participating clinical trial last 90 day 2 . Have COPD 3 . With asthma exacerbation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>asthma</keyword>
</DOC>